AR004198A1 - Un compuesto azo del acido 5-aminosalicilico y procedimiento para preparar el mismo - Google Patents
Un compuesto azo del acido 5-aminosalicilico y procedimiento para preparar el mismoInfo
- Publication number
- AR004198A1 AR004198A1 ARP960104275A AR10427596A AR004198A1 AR 004198 A1 AR004198 A1 AR 004198A1 AR P960104275 A ARP960104275 A AR P960104275A AR 10427596 A AR10427596 A AR 10427596A AR 004198 A1 AR004198 A1 AR 004198A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- aryl
- cycloalkyl
- formula
- nr7c
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La invención se refiere a fórmula (I), en donde: el radical 4-hidroxi-3- carboxifenilazo puede estar en la posición 3 ó 4 del anillo bencénico; mrepresenta 1 ó 2; R1 representa C1-4 alquilo ó C3-7 cicloalquilo; a, b y c representan CR2,donde cada R2 independientemente representa H ó C1-4 alquilo;X representa un grupo de fórmula (i) ó (ii); A representa -CO-, -SO2-, -NHCO- ó -OCO-; B representa un grupo de fórmula (iii), y cuando A representa -CO- ó-SO2-, B también puederepresentar un g rupo de fórmula (iv), (v), (vi) ó (vii); n representa 0, 1, 2, ó 3; p representa 0 ó 1; R3 representa H; C1-4 alquilo,C1-4 haloalquilo, C3-7 cicloalquilo, C1-4 alcoxi-C1-4 alquilo ó arilo; R4 representa H, C1-4 alquilo, -COOR5ó -CONR5R6, y cua ndo A representa -CO- ó-SO2-, entonces R4 puede ser también -NR5R6, -NR7C(=O)OR5, -NR7C(=O)R5, -NR7C(=O)NR5R6 ó -NR7SO2R5; ó bien R3 y R4 juntos forman una cadena de C2-6polimetileno; R5 representa C1-4 alquilo, arilo oaril-C1-4 alquilo; R6 y R7 representan independientemente H ó C1-4 alquilo; W representa -OC(=O)-,-C(=O)-,-NR6C(=O)- ó -SO2-; R8 representa arilo; R9 representa C1-4 alquilo,C3-7 cicloalquilo, -C(=O)OR5, -C(=O)R5, -C(=O)NR5R6, ó -SO2R5;R10 representa C1-4alquil o, C3-7 cicloalquilo, arilo, ó aril-C1-4 alquilo; Z representa -(CH2)qCO- ó -(CH2)r-; q representa 0, 1, ó 2; r representa 1 ó 2; R11 representa H óhalógeno; R12 y R13 representan independientemente H, C1-6 alquilo,C3-7cicloalquilo ó C3-7 ci cloalquil-C1-6 alquilo;o bien R12 y R13 juntos forman unacadena de C2-6 polimetileno;R14 representa -COR15, -COOH,-COOR15, -CONR16R17; -C1-6 alquil-OR15, -C1-6 alquil-OC(=O)R15 ó -C1-6 alquil-OC(=O)NR16R17; R15representaC1-6 alquilo, C2-6 alquenil o, C2-6 alquinilo, C3-7cicloalquilo ó C1-6 haloalquilo; R16 y R17 representan independientemente H o cualquiera de
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9501752A ES2106682B1 (es) | 1995-09-08 | 1995-09-08 | Nuevos derivados azo del acido 5-aminosalicilico. |
| ES9501967A ES2104513B1 (es) | 1995-10-11 | 1995-10-11 | Nuevos derivados del acido 5-aminosalicilico. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR004198A1 true AR004198A1 (es) | 1998-11-04 |
Family
ID=26154915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960104275A AR004198A1 (es) | 1995-09-08 | 1996-09-06 | Un compuesto azo del acido 5-aminosalicilico y procedimiento para preparar el mismo |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5747477A (es) |
| EP (1) | EP0790998B1 (es) |
| JP (1) | JP4115522B2 (es) |
| KR (1) | KR100481300B1 (es) |
| AR (1) | AR004198A1 (es) |
| AT (1) | ATE198751T1 (es) |
| AU (1) | AU6987596A (es) |
| BR (1) | BR9606628A (es) |
| CA (1) | CA2204747C (es) |
| DE (1) | DE69611598T2 (es) |
| DK (1) | DK0790998T3 (es) |
| ES (1) | ES2155621T3 (es) |
| GR (1) | GR3035622T3 (es) |
| MX (1) | MX9702919A (es) |
| NO (1) | NO308850B1 (es) |
| PT (1) | PT790998E (es) |
| WO (1) | WO1997009329A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6958324B2 (en) * | 1998-12-02 | 2005-10-25 | Inotek Pharmaceuticals Corporation | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease |
| ES2165803B1 (es) * | 2000-04-10 | 2003-09-16 | Uriach & Cia Sa J | Nueva sal de un derivado azo del acido 5-aminosalicilico |
| AU2001268607A1 (en) | 2000-06-21 | 2002-01-02 | Bristol-Myers Squibb Company | Piperidine amides as modulators of chemokine receptor activity |
| AU2001285311B2 (en) * | 2000-08-29 | 2005-09-15 | Biocon, Ltd | Immunoregulatory compounds, derivatives thereof and their use |
| US8048924B2 (en) * | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
| WO2003026651A1 (en) * | 2001-09-28 | 2003-04-03 | Indevus Pharmaceuticals, Inc. | Method of inhibiting the production and/or effects of intestinal pro-inflammatory cytokines, prostaglandins and others |
| EP1773767B1 (en) | 2004-07-07 | 2016-03-09 | Biocon Limited | Synthesis of azo bonded immunoregulatory compounds |
| US7498355B2 (en) | 2005-05-27 | 2009-03-03 | Antibe Therapeutics Inc. | Derivatives of 4- or 5-aminosalicylic acid |
| US7741359B2 (en) | 2005-05-27 | 2010-06-22 | Antibe Therapeutics Inc. | Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
| WO2006125293A1 (en) | 2005-05-27 | 2006-11-30 | Antibe Therapeutics Inc. | Derivatives of 4- or 5-aminosalicylic acid |
| CA2653869A1 (en) | 2006-06-06 | 2007-12-13 | Antibe Therapeutics Inc. | Salts of trimebutine and n-desmethyl trimebutine |
| US7645801B2 (en) * | 2007-01-29 | 2010-01-12 | Alaven Pharmaceutical Llc | Reduced irritant enema for treatment of inflammatory bowel disease (IBD) |
| CN105566153B (zh) * | 2014-10-14 | 2019-05-31 | 中国医学科学院药物研究所 | 偶氮苯衍生物及其制法和药物组合物与用途 |
| WO2019245225A1 (ko) | 2018-06-19 | 2019-12-26 | (주)코엔바이오 | 류코노스톡속 균주를 포함하는 장 기능 개선용 조성물 |
| KR102173168B1 (ko) | 2018-06-19 | 2020-11-03 | 주식회사 엠디헬스케어 | 류코노스톡속 균주를 포함하는 장 기능 개선용 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2396145A (en) * | 1940-12-14 | 1946-03-05 | Pharmscia Ab | Heterocyclic sulphonamido azo compounds |
| US4312806A (en) * | 1981-03-02 | 1982-01-26 | G. D. Searle & Co. | Method and compounds for treating inflammatory bowel disease |
| PT98673B (pt) * | 1990-08-15 | 1999-01-29 | British Bio Technology | Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de benzimidazole e de seus intermediarios |
| GB9202791D0 (en) * | 1992-02-11 | 1992-03-25 | British Bio Technology | Compounds |
| ES2087038B1 (es) * | 1994-11-07 | 1997-03-16 | Uriach & Cia Sa J | Nuevas piperidinas con actividad antagonista del paf. |
-
1996
- 1996-09-06 DE DE69611598T patent/DE69611598T2/de not_active Expired - Lifetime
- 1996-09-06 MX MX9702919A patent/MX9702919A/es unknown
- 1996-09-06 DK DK96931039T patent/DK0790998T3/da active
- 1996-09-06 EP EP96931039A patent/EP0790998B1/en not_active Expired - Lifetime
- 1996-09-06 BR BR9606628A patent/BR9606628A/pt not_active IP Right Cessation
- 1996-09-06 PT PT96931039T patent/PT790998E/pt unknown
- 1996-09-06 JP JP51087597A patent/JP4115522B2/ja not_active Expired - Fee Related
- 1996-09-06 AR ARP960104275A patent/AR004198A1/es active IP Right Grant
- 1996-09-06 AU AU69875/96A patent/AU6987596A/en not_active Abandoned
- 1996-09-06 US US08/836,125 patent/US5747477A/en not_active Expired - Lifetime
- 1996-09-06 WO PCT/EP1996/003921 patent/WO1997009329A1/en not_active Application Discontinuation
- 1996-09-06 CA CA002204747A patent/CA2204747C/en not_active Expired - Fee Related
- 1996-09-06 KR KR1019970703002A patent/KR100481300B1/ko not_active IP Right Cessation
- 1996-09-06 ES ES96931039T patent/ES2155621T3/es not_active Expired - Lifetime
- 1996-09-06 AT AT96931039T patent/ATE198751T1/de active
-
1997
- 1997-05-07 NO NO972113A patent/NO308850B1/no not_active IP Right Cessation
-
2001
- 2001-03-23 GR GR20010400467T patent/GR3035622T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT790998E (pt) | 2001-04-30 |
| CA2204747C (en) | 2009-05-05 |
| DK0790998T3 (da) | 2001-02-05 |
| DE69611598D1 (de) | 2001-02-22 |
| WO1997009329A1 (en) | 1997-03-13 |
| JPH11501939A (ja) | 1999-02-16 |
| NO972113L (no) | 1997-05-07 |
| US5747477A (en) | 1998-05-05 |
| DE69611598T2 (de) | 2001-06-07 |
| CA2204747A1 (en) | 1997-03-13 |
| KR100481300B1 (ko) | 2005-07-29 |
| KR970707125A (ko) | 1997-12-01 |
| AU6987596A (en) | 1997-03-27 |
| NO972113D0 (no) | 1997-05-07 |
| JP4115522B2 (ja) | 2008-07-09 |
| EP0790998B1 (en) | 2001-01-17 |
| BR9606628A (pt) | 1997-09-30 |
| ATE198751T1 (de) | 2001-02-15 |
| GR3035622T3 (en) | 2001-06-29 |
| MX9702919A (es) | 1998-04-30 |
| ES2155621T3 (es) | 2001-05-16 |
| EP0790998A1 (en) | 1997-08-27 |
| NO308850B1 (no) | 2000-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR004198A1 (es) | Un compuesto azo del acido 5-aminosalicilico y procedimiento para preparar el mismo | |
| DK208786D0 (da) | (meth)-acrylsyreester deres fremstilling og anvendelse paa dentalomraadet | |
| DK0541168T3 (da) | HIV-proteaseinhibitorer, som er egnede til behandling af AIDS | |
| NO951543D0 (no) | Polyenforbindelser, farmasöytiske og kosmetiske preparater inneholdende disse, og deres anvendelser | |
| AR031716A1 (es) | Derivados de 1-aza y 1,3- diazabicicloetanos y analogos, un procedimiento para su preparacion, y composicion farmaceutica y medicamentos como antibacterianos | |
| DE3855144D1 (de) | Verwendung von bestimmten 5-HT3-Rezeptorantagonisten zur Behandlung von Eingeweideschmerzen | |
| FI972062A0 (fi) | Substituoituja 4-biaryylivoi- tai 5-biaryylipentaanihappoja ja johdannaisia matriisimetalliproteaasi-inhibiittoreina | |
| DK1163212T3 (da) | Amidderivater | |
| DK287786A (da) | (meth)-acrylsyre-derivater af tricyclodecaner, deres fremstillingog anvendelse som monomere til dentalmaterialer | |
| FI935778A (fi) | HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten | |
| AR039341A1 (es) | Derivados de 2,6-quinolinilo y 2,6-naftilo, procesos para su preparacion y sus usos | |
| TR200103337T2 (tr) | Protez inhibitrleri olarak yeni bileçikler ve bileçimler | |
| DE69334250D1 (de) | Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern | |
| NO20034644D0 (no) | Fettsyrer med halvlange kjeder, glycerider og analoger som neutrofile overlevelses- og aktiveringsfaktorer | |
| AR040257A1 (es) | Profarmacos de aminoacidos excitadores | |
| DE60319269D1 (de) | Pharmazeutische verwendungen von 2-substituierten 4-heteroarylpyrimidinen | |
| FR2676734B1 (fr) | Nouveaux derives de la pyrimidine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. | |
| AR013171A1 (es) | Compuestos derivados de azetidinas, su uso para la elaboracion de medicamentos, procedimientos de tratamiento, procesos para su preparacion, ycompuestos utiles en su preparacion | |
| FI935779A (fi) | HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten | |
| EA199800602A1 (ru) | N-ацил-2-замещенный-4-(бензимидазолил- или имидазопиридинил -замещенные остатки)-пиперидины как антагонисты тахикинина | |
| FI20000553A (fi) | Proteaasi-inhibiittoreina käyttökelpoisten 4-hydroksi-2-oksopyraanijohdannaisten valmistusmenetelmä | |
| AR016501A1 (es) | Compuestos inhibidores de las fkbp, composiciones farmaceuticas, uso para la preparacion de medicamentos y procesos de preparacion e intermediarios. | |
| RS50072B (sr) | S-nitrozotioli kao agensi za tretman cirkulatornih poremećaja | |
| RU2002106409A (ru) | Антибактериальные агенты | |
| DE69205383T2 (de) | N,N',N'-trisubstituierte 5-Bisaminomethylen-1,3-Dioxan-4,6-Dione als Acyl-CoA: Cholesterol-Acyltransferasehemmer. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |